-
'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?
-
Nathan S. S. Atkinson, D. John M. Reynolds, Simon P. L. Travis
-
Intest Res 2015;13(3):227-232. Published online June 9, 2015
-
DOI: https://doi.org/10.5217/ir.2015.13.3.227
-
-
Abstract
PDF PubReader
Proton pump inhibitors (PPIs) are widely used though an association with hypomagnesaemia and hypocalcaemia has only been described since 2006. Patients typically present after years of stable dosing with musculoskeletal, neurological or cardiac arrhythmic symptoms, but it is likely that many cases are under-recognised. Magnesium levels resolve rapidly on discontinuation of PPI therapy and hypomagnesaemia recurs rapidly on rechallenge with any agent in the class. The cellular mechanisms of magnesium homeostasis are increasingly being understood, including both passive paracellular absorption through claudins and active transcellular transporters, including the transient receptor potential channels (TRPM6) identified in the intestine and nephron. PPIs may alter luminal pH by modulating pancreatic secretions, affecting non-gastric H+K+ATPase secretion, altering transporter transcription or channel function. A small reduction in intestinal absorption appears pivotal in causing cumulative deficiency. Risk factors have been associated to help identify patients at risk of this effect but clinical vigilance remains necessary for diagnosis.
-
Citations
Citations to this article as recorded by 
- Use of Acid-Suppression Therapy and Odds of Migraine and Severe Headache in the National Health and Nutrition Examination Survey
Margaret Slavin, Cara L. Frankenfeld, Alexander B. Guirguis, Elizabeth K. Seng Neurology Clinical Practice.2024;[Epub] CrossRef - Magnesium Homeostasis
Aubrey R. Morrison Clinical Journal of the American Society of Nephrology.2023; 18(7): 969. CrossRef - Risk of urinary stone formation associated to proton pump inhibitors: A systematic review and metanalysis
Rawa Bapir, Kamran Hassan Bhatti, Ahmed Eliwa, Herney Andrés García-Perdomo, Nazim Gherabi, Derek Hennessey, Vittorio Magri, Panagiotis Mourmouris, Adama Ouattara, Gianpaolo Perletti, Joseph Philipraj, Konstantinos Stamatiou, Musliu Adetola Tolani, Lazaro Archivio Italiano di Urologia e Andrologia.2022; 94(4): 507. CrossRef - An overview of diagnosis and management of drug‐induced hypomagnesemia
George Liamis, Ewout J. Hoorn, Matilda Florentin, Haralampos Milionis Pharmacology Research & Perspectives.2021;[Epub] CrossRef - Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
Yi-Chao Shi, Shun-Tian Cai, Ya-Ping Tian, Hui-Jun Zhao, Yan-Bing Zhang, Jing Chen, Rong-Rong Ren, Xi Luo, Li-Hua Peng, Gang Sun, Yun-Sheng Yang Genomics, Proteomics & Bioinformatics.2019; 17(1): 52. CrossRef - Atrial fibrillation and gastrooesophageal reflux disease: association mechanisms, treatment approaches
O. N. Antropova, N. V. Pyrikova, I. V. Osipova Russian Journal of Cardiology.2019; (7): 103. CrossRef - Do stop me now: gastric acid-reducing drugs following renal transplantation
Ines Held, Rhodri Pyart Journal of Kidney Care.2018; 3(1): 6. CrossRef - Magnesium homeostasis in cattle: absorption and excretion
Holger Martens, Sabine Leonhard-Marek, Monika Röntgen, Friederike Stumpff Nutrition Research Reviews.2018; 31(1): 114. CrossRef - A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors
Li-Yuan Yu, Lu-Ning Sun, Xue-Hui Zhang, Yue-Qi Li, Lei Yu, Zi-Qing-Yun Yuan, Ling Meng, Hong-Wen Zhang, Yong-Qing Wang Advances in Therapy.2017; 34(5): 1070. CrossRef - Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis
Young Joo Yang, Chang Seok Bang, Gwang Ho Baik, Tae Young Park, Suk Pyo Shin, Ki Tae Suk, Dong Joon Kim BMC Gastroenterology.2017;[Epub] CrossRef - Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
Jung Hwa Min, You Sun Kim Gut and Liver.2016; 10(4): 493. CrossRef - Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study
Cheol Min Shin, Nayoung Kim, Yong Sung Kim, Ryoung Hee Nam, Ji Hyun Park, Dong Ho Lee, Yeong-Jae Seok, Yeon-Ran Kim, Joo-Hyon Kim, Jung Min Kim, Joo Sung Kim, Hyun Chae Jung Gut and Liver.2016; 10(6): 896. CrossRef
-
12,211
View
-
72
Download
-
12
Web of Science
-
12
Crossref
|